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Purpose.Myocardial blood flow (MBF) quantification with 82Rb positron emission tomography (PET) is gaining clinical adoption,
but improvements in precision are desired. This study aims to identify analysis variants producing the most repeatable MBF
measures. Methods. 12 volunteers underwent same-day test-retest rest and dipyridamole stress imaging with dynamic 82Rb PET,
from which MBF was quantified using 1-tissue-compartment kinetic model variants: (1) blood-pool versus uptake region sampled
input function (Blood/Uptake-ROI), (2) dual spillover correction (SOC-On/Off), (3) right blood correction (RBC-On/Off), (4)
arterial blood transit delay (Delay-On/Off), and (5) distribution volume (DV) constraint (Global/Regional-DV). Repeatability
of MBF, stress/rest myocardial flow reserve (MFR), and stress/rest MBF difference (ΔMBF) was assessed using nonparametric
reproducibility coefficients (RPCnp = 1.45 × interquartile range). Results.MBF using SOC-On, RVBC-Off, Blood-ROI, Global-DV,
and Delay-Off was most repeatable for combined rest and stress: RPCnp = 0.21mL/min/g (15.8%). Corresponding MFR and ΔMBF
RPCnp were 0.42 (20.2%) and 0.24mL/min/g (23.5%). MBF repeatability improved with SOC-On at stress (𝑝 < 0.001) and tended
to improve with RBC-Off at both rest and stress (𝑝 < 0.08). DV and ROI did not significantly influence repeatability.TheDelay-On
model was overdetermined and did not reliably converge. Conclusion. MBF and MFR test-retest repeatability were the best with
dual spillover correction, left atrium blood input function, and global DV.
1. Introduction
Repeatable myocardium blood flow (MBF) measurements
are essential to detect minute changes in myocardial perfu-
sion due to disease progression or in response to therapy,
as well as for accurate clinical classification in comparison
to population databases. Quantification of MBF requires a
series of image analysis steps including the use of a tracer
kinetic model and accurate correction for partial-volume
losses (and corresponding signal mixing effects) [1]. Various
models have been investigated in the literature [2], but
most commonly a 1-tissue-compartment model (also known
as the 2-compartment model) with a tissue-blood volume
estimation is used to describe the kinetics of 82Rb [3]. Models
are often simplified to improvemodel stability and robustness
in the presence of image noise; however, this is poten-
tially at the expense of physiological or physical complete-
ness.
Various factors influence repeatability. Schindler et al. [4]
and Efseaff et al. [5] evaluated elements of image reconstruc-
tion. Klein et al. [6] evaluated tracer infusion. DeKemp et al.
[7] and Bravo et al. [8] looked at the agreement in software
implementation. Moody et al. [9] looked at the effects of the
tracer extraction function on MBF variance. In this work,
we focused on reducing the variability introduced by the 1-
tissue-compartment kinetic model, by comparing previously
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Figure 1: Rest and stress imaging protocol.
described variants of it, thus attempting to identify the most
repeatable kinetic model variant.
Previous work by our team evaluated MBF repeatability
using rest imaging alone and reported a test-retest repeata-
bility coefficient (95% limits of agreement) as low as 20% [5]
using optimal image reconstruction parameters.These results
were confirmed using both cardiac-rest and cardiac-stress
imaging in a recent study by our group that concluded better
repeatability using constant-activity (versus constant-flow)
infusion of 82Rb tracer and using a 1-tissue-compartment
model (versus a simplified retention model) [6]. The present
study expands on these previous studies to determine most
precise 1-tissue-compartment model variants. Thus, our goal
in this study was twofold: (1) to elucidate the effects of
more physically and physiologically complete kinetic model
variants on MBF repeatability and (2) to identify the 1-
tissue kinetic model variant which achieves the most precise
MBF quantification. In this work, we describe alternative
variants of the 1-tissue-compartment model and compare
their repeatability for quantifying MBF and MFR with 82Rb
PET using a single imaging session, test-retest study.
2. Materials and Methods
2.1. Patient Recruitment and Preparation. This study rean-
alyzed the constant-activity (CA) cohort data previously
reported in [6]. Study participants were instructed to abstain
from caffeine intake for 12 hours, fast for 4 hours (except
for water intake), and withhold medication according to
standard clinical guidelines prior to the exam [10]. Clinical
demographics, cardiac risk factors, and history of cardiac
procedures and medications were recorded for each subject.
Patients with acute coronary syndrome or unstable angina,
heart failure, pulmonary edema, severe valve disease, or
contraindication to dipyridamole such as hypotension, heart
block, or asthma were excluded. All participants provided
written informed consent. The study was approved by the
Human Research Ethics Board at the University of Ottawa
Heart Institute (UOHI). Due to technical reasons that are
explained later, one patient was excluded from the study.
2.2. Image Acquisition Protocol. A modified clinical protocol
[11], as illustrated in Figure 1, was used to acquire two rest and
two stress scans in a single session, in an attempt to maintain
consistent patient positioning and hemodynamic conditions
between test and retest. Patients were positioned in a Discov-
ery 690 PET/VCT scanner (GE Healthcare, Waukesha, WI)
with ECG leads placed for patient monitoring and cardiac
gating. Patient heart rates, blood pressure, and symptoms of
ischemia were monitored throughout the imaging session.
A scout scan was performed for patient positioning,
followed by a low-dose (<0.3mSv) normal end-expiration
breath-hold CT for attenuation correction. Four PET list-
mode scans were acquired, each following 10MBq/kg of
82Rb administered as a constant-activity [12] “square-wave”
infusion over a 30-second interval using a RubyFill-V2
infuser (Jubilant DraxImage, Kirkland, QC). This was done
to limit the scanner coincidence dead-time to <35% for
accurate measurement of the bolus first-pass activity, while
ensuring sufficient counts to achieve high quality uptake and
ECG-gated images for routine myocardial perfusion imaging
(MPI) interpretation [6, 13]. All scans were initiatedmanually
after 82Rb infusion was started and the PET scanner reported
that coincidence count rates exceeded 10 kcps.
The first rest scan (test) was followed immediately
by a second (retest). The stress agent, dipyridamole
(0.14mg/kg/min), was infused for 5 minutes, and 3
minutes later two stress image acquisition procedures
(test + retest) were performed in quick succession, as shown
in Figure 1. Fourminutes after starting the second stress scan,
aminophylline was administered to the patient to reduce
symptoms.
2.3. Image Reconstruction. PET images were manually ad-
justed, if necessary, for optimal registration with the CT data
to ensure accurate attenuation correction. List-mode scan
data were binned into 14 time frames (10 s × 9, 30 s × 3, 60 s
× 1, 120 s × 1) and iteratively reconstructed using the vendor
OSEM method (VuePointHD, 24 subsets, 4 iterations) with
an 8mm 3D Hann postfilter and were corrected for physical
decay of the tracer [5].
2.4. Image Analysis. All images were processed using in-
house custom MBF quantification software, FlowQuant
v.2.4 (UOHI, Ottawa, ON), by a single operator to ensure
consistent image orientation and segmentation (see SM
1). Late uptake-phase (2–6min) images were automatically
reoriented, with optional operator intervention to produce
short-axis (SA) slices through the left ventricle (LV). The
LV myocardium was then segmented into 496 individual
sectors in which the arterial time-activity curves (TACs) were
sampled [11]. Ventricular and atrial cavity regions of interest
(ROIs) were also segmented to generate arterial TACs as
detailed in the Arterial Input ROI. All the other processing
was completely automated and was therefore free of any
potential operator bias. All model variants were based on the
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commonly used 1-tissue-compartment model [11], in which
the tracer activity in the myocardial tissue is modeled as
𝐶𝑡 (𝑡) = 𝐾1𝑒−𝑘2𝑡 ⊗ 𝐶blood (𝑡)
= 𝐾1𝑒−(𝐾1/DV)𝑡 ⊗ 𝐶blood (𝑡) ,
(1)
where 𝐶𝑡(𝑡) is the modeled time-dependent myocardial
tissue activity concentration, 𝐾1 is the 82Rb uptake rate
in mL/min/g, 𝑘2 is the 82Rb rate of washout from the
myocardium in min−1, 𝐶blood(𝑡) is the image-derived tracer
concentration in arterial blood, and ⊗ is the discrete convo-
lution operator. DV is the distribution volume, the ratio of tis-
sue, and blood tracer concentrations after the compartments
reach equilibrium and can be expressed as
DV = 𝐾1𝑘2
. (2)
For each polar map sector, the myocardial image concentra-
tion was modeled as
𝐶myo (𝑡) = FBV × 𝐶blood (𝑡) + (1 − FBV) × 𝐶𝑡 (𝑡) , (3)
where FBV represents the fractional blood volume (unitless)
and (1 − FBV) was used to correct for regional recovery of
partial-volume losses in the myocardium [14]. The 𝐾1 and
FBV parameters were estimated using (1) and (3) for each
sector of the LVmyocardium, via weighted (by frame length)
nonlinear least squares minimization of differences between
the modeled and the sampled myocardium TACs, 𝐶myo(𝑡).
An extraction correction function 𝐸(MBF), as defined by
Lortie et al. [15], was used to convert𝐾1 values to MBF:
𝐾1 = (1 − 0.77𝑒−0.63/MBF)MBF. (4)
Variants of the model are described in the next 5 sections.
2.4.1. Distribution Volume. We explored two variants of the
distribution volume: (1) with a free DV parameter (Regional-
DV) and (2) with a spatially uniform DV constant (Global-
DV) that was determined by fitting the free model to the
normal uptake region within the polar map (>75% maxi-
mum) [5]. By using a constant value for DV, the number
of model parameters is reduced, thereby increasing the
model optimization robustness, potentially at the expense of
regional accuracy.
2.4.2. Spillover Correction (SOC). The image-derived arterial
input function, 𝐶blood(𝑡), may be contaminated by spillover
signal from the myocardium into the LV cavity due to the
limited image spatial resolution. A practical dual-spillover
correction technique [5] was used to derive a pure blood
signal 𝐶𝑏(𝑡) that replaces 𝐶blood(𝑡) as the input function to
the kinetic model. The image-sampled TACs for blood and
whole-LV average, 𝐶blood(𝑡) and 𝐶myo wholeLV(𝑡), respectively,
were assumed to consist of a complementary mix of pure
blood, 𝐶𝑏(𝑡), and pure myocardial tissue signals, 𝐶𝑡(𝑡), such
that
𝐶myo wholeLV (𝑡) = FBV × 𝐶𝑏 (𝑡) + (1 − FBV)
× 𝐶𝑡 wholeLV (𝑡) ,
𝐶blood (𝑡) = 𝛽 × 𝐶𝑏 (𝑡) + (1 − 𝛽) × 𝐶𝑡 wholeLV (𝑡) ,
(5)
where 𝛽 is the fraction of pure blood signal in image-sampled
blood TAC (typically in the order of 85% [16]).Thus, the pure
blood signal, 𝐶𝑏(𝑡), can be derived from (5), as a function of
𝐶blood(𝑡) and 𝐶myo wholeLV(𝑡), using
𝐶𝑏 (𝑡)
=
(1 − FBV) × 𝐶blood (𝑡) − (1 − 𝛽) × 𝐶myo wholeLV (𝑡)
𝛽 × (1 − FBV) − (1 − 𝛽) × FBV .
(6)
In this approach, (1) and (5) were used to approximate 𝐾1,
𝑘2, FBV, and 𝛽 based on the average whole-LV values of
𝐶myo wholeLV(𝑡) and using the same weighted nonlinear least
squares minimization with a penalty for negative 𝐶𝑏(𝑡) and
𝐶𝑡(𝑡) values and residual blood activity in late time frames
(last 4 minutes) [5]. Based on this estimate of 𝛽, (6) provided
a new TAC for 𝐶𝑏(𝑡) that, once substituted as the blood
input function 𝐶blood(𝑡) in (1) and (2), allowed for regional
estimates of MBF for each polar map sector.
2.4.3. Arterial Input ROI. Two blood regions were derived,
from which the arterial input function, 𝐶blood(𝑡), could be
sampled (average of all pixel values within the ROI).
Uptake-ROI. Three (atrium, base, and cavity) warped cylin-
ders (8mm diameter) were positioned in the LV blood cavity
so as to maximize their distance from the myocardial wall in
each short-axis plane. Each region was sampled individually
and the median intensity at each time frame was used to
generate the blood input function𝐶blood-uptake-ROI(𝑡) [11]. The
three regions are shown asA (atrium), B (base), andC (cavity)
in Figure 2.
Blood-ROI.The blood-pool frame was determined using the
point of maximum activity in 𝐶blood-uptake-ROI(𝑡). The early
blood-pool image was then masked to include only regions
beyond the LV mitral valve plane (i.e., atrium and aorta)
on which a threshold (85% of maximum) was applied. This
regionwas then sampled to generate the blood input function
𝐶blood-ROI(𝑡) [5], shown as the red patch in Figure 2.
2.4.4. Right Blood Correction (RBC). RV blood contami-
nation of the sampled LV myocardium TAC is expected,
particularly in the septal wall region. Thus, the following
revised model accounting for RV blood spillover was derived
previously [14] and investigated [17]:
𝐶myo (𝑡) = LVBV × 𝐶blood (𝑡) + RVBV × 𝐶rv (𝑡)
+ (1 − LVBV − RVBV) × 𝐶𝑡 (𝑡) ,
(7)
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Figure 2: FlowQuant sampling of LV myocardium and arterial blood regions. On the left (from left to right, top to bottom), there are short-
axis (SA) planes, which are consecutive slices through the horizontal and vertical long axis (HLA and VLA, resp.), shown on the right. The
RA cavity pixels are shown in green, and the LA cavity pixels are shown in red. Late uptake frame derived LV blood-pool regions are shown
as A (atrium), B (base), and C (cavity) regions in the HLA and VLA and as circles in the SA slices.
where LVBV is the left ventricle blood fraction, RVBV is the
right ventricle blood fraction, and 𝐶rv(𝑡) is the TAC in the
right ventricle blood pool. To sample 𝐶rv(𝑡), an RV blood
ROI was derived on the frame preceding (10 sec) the peak
LV blood, using a mask extending radially beyond the septal
wall and applying a threshold at 85% of the maximum blood
activity, as shown in green in Figure 2. RBCwas implemented
by substituting (3) with (7) in the septal half of the LV polar
map and thus could be utilizedwith orwithout SOC,with any
kinetic model, and with either Blood- or Uptake-ROI.
2.4.5. Delay between LeftVentricle Cavity andMyocardium. A
final modification to the standardmodel accounted for blood
transport delay between left chambers of the heart and the
perfused myocardium as follows:
𝐶𝑡 (𝑡) =
{
{
{
𝐾1𝑒−(𝐾1/DV)(𝑡−delay) ⊗ 𝐶blood (𝑡) , 𝑡 > delay
0 𝑡 ≤ delay.
(8)
To our knowledge, this transport delay has not been previ-
ously modeled in the context of cardiac PET. A similar delay
is used in cardiac CT where the temporal resolution is much
higher (∼1 sec) [18].
2.5. Myocardial Blood Flow Analysis. All combinations of the
model variants (25 = 32 in total) were evaluated. Average rest
and stress MBF, MFR, and ΔMBFwere measured in the three
coronary artery territories: left anterior descending artery
(LAD), left circumflex artery (LCX), and right coronary
artery (RCA), according to the American Heart Association
guidelines [19]. These are reported throughout this work.
Using (4), the flow values using SOC-On Global-DV
were significantly reduced compared to SOC-Off Global-DV
and all of the Regional-DV values, which were previously
calibrated to 13N-ammonia flow values [15]. In order to
preserve MBF accuracy, a separate calibration (extraction
correction) function was derived to correct for this bias by
minimizing the mean squared error between the SOC-On
Global-DV and the rest of the MBF values. The resulting
extraction function for SOC-On was determined to be
𝐾1 = (1 − 0.76𝑒−0.40/MBF)MBF. (9)
2.6. Data Quality Assurance. As part of routine quality assur-
ance, a gamma-variate function was fitted to the blood TACs
of each scan to ensure consistency of the blood TACs between
test-retest scans, with typical profiles. The fitted parameters
were used to resolve the following metrics: rise time (𝑡rise),
clearance time (𝑡clearance), and mean transit time (𝑡mean-transit)
[20]. Scans with outlying gamma-variate parameters were
excluded from further analysis, due to inconsistent tracer
injection profiles.
2.7. Statistical Analysis. Continuous and discrete data are pre-
sented as mean ± standard deviation [minimum,maximum].
Test-retest analysis was performed using Spearman correla-
tion (𝜌). Additionally, Bland-Altman analysis was performed.
Nonparametric tests were used to account for outliers and
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Table 1: Patient demographics (𝑛 = 12).
Healthy volunteers/CAD patients 2/10
Sex (females/males) 5/7
Age (mean ± SD [range]) 61.1 ± 11 [46–81] years
BMI (mean ± SD [range]) 32.9 ± 5.9 [24–43]m2/kg
Diabetic (no/IDDM/NIDDM) 10/1/1
Smoker (never/current/past > 1 yr) 6/3/3
BMI: body mass index.
IDDM: insulin-dependent diabetes mellitus (type 1).
NIDDM: non-insulin-dependent diabetes mellitus (type 2).
non-Gaussian distribution of the data. Differences in repeat
flow measurements were calculated both in absolute terms
and in relative percentage to the means of test and retest.
For normally distributed difference data, absolute and relative
repeatability coefficients (RPC = 1.96 ∗ standard deviation)
are typically used to summarize the data. However, we noted
that the flow differences data do not follow a normal distribu-
tion so nonparametric repeatability coefficients (RPCnp) were
presented as a measure of data variability (RPCnp = 1.45 ×
interquartile range − IQR). For normally distributed data,
RPCandRPCnp are equivalent [21, 22]. In order to account for
systemic biases, median rest and stress MBF differences were
subtracted, respectively, to force the medianMBF differences
to zero. We evaluated whether differences in rate pressure
product (RPP) correlated with differences in flow. Wilcoxon
and Levene’s tests were used to test the statistical significance
of differences in medians and variances, respectively [23]. 𝑝
values < 0.05 were considered statistically significant. All the
analysis was performed in Matlab R2013b.
3. Results
3.1. Patient Demographics. Twelve participants were recruit-
ed for this study, including 2 healthy volunteers and 10
patients with known or suspected CAD referred for clinical
diagnostic testing. The demographic and hemodynamic data
of these patients are detailed in Tables 1 and 2, respectively.
No RPP adjustments of rest or stress MBF values were
performed, since the test-retest changes in MBF (delta) were
not significantly correlated with changes in RPP (𝑅 < 0.30;
𝑝 = NS). As expected, retest versus test RPP values were
highly correlated (𝑅 ≥ 0.90; 𝑝 < 0.001). A small but
statistically significant increase in retest MBF was registered
at stress (Table 3).
3.2. Patient Hemodynamics. Subject hemodynamicmeasure-
ments are summarized in Table 2. No significant differences
were found between test and retest for either heart rate or
blood pressure at rest or stress, confirming stable hemo-
dynamics. Rate pressure products (RPP) were significantly
higher at stress compared to rest, confirming hemodynamic
response to the stressor. Based on these population averages,
rest and stressMBF values were normalized bymultiplying by
the population average RPP (8240 and 10638 bpm × mmHg
for rest and stress, resp.) and dividing by the study specific
RPP to reduce RPP related variability in MBF. However, this
did not improve the results and in fact it made them worse,
likely due to the propagation of RPP error (data not shown);
thus, only non-RPP-adjusted values are reported.
3.3. Flow, Flow Reserve, and Flow Delta Values. Rest and
stressMBF values are summarized in Figure 3 using boxplots.
As expected, all methods showed significantly higher flow
values at stress versus at rest (𝑝 < 0.0001), indicating effective
response of the patients to the stressor and the ability of MBF
to distinguish between physiologic states. The model variant
with Blood-ROI, SOC-On, RBC-Off, Delay-Off, and Global-
DV has been characterized previously [9] and was therefore
selected as a reference method to which the other methods
were compared. 𝐾1, MBF, and RPP-adjusted MBF values for
this model are summarized in Table 3.
The transport Delay-On model was determined to have
poor convergence and therefore was only reportedwith SOC-
On, RBC-Off, Blood-ROI, and Global-DV. Detailed results
for this model and the remaining 16 model variants are listed
in Figure 4.
No significant differences in mean MBF values were
measured between themodel variants (RBC-Off versus RBC-
On, Blood-ROI versus Uptake-ROI, and Global-DV versus
Regional-DV) at either rest or stress usingWilcoxon analysis,
which indicates no biases betweenmethods. Likewise, no bias
wasmeasured for SOC-On versus SOC-Off due to calibration
of the extraction correction function using the same dataset,
as described.
3.4. Test-Retest Repeatability of Kinetic Model Variants.
Repeatability coefficients (absolute and relative RPCnp) are
presented in Figure 4 for the various methods. The most
repeatable method (with the lowest RPCnp values) is empha-
sized and corresponds to the reference method. The corre-
sponding correlation and relative Bland-Altman analysis of
MBF values are demonstrated in Figure 5 for the reference
method.
The individual effects of the model parameters on test-
retest repeatability are shown in Figure 6. SOC-On had
significantly lower test-retest flow differences than SOC-Off
(𝑝 < 0.001 at stress). RBC-Off tended to be more repeatable
than RBC-On (𝑝 < 0.08) but did not reach significance.
Global-DV and blood input ROI model variants did not
result in a significant difference in test-retest flow differences.
Uptake-ROI was as repeatable as Blood-ROI, regardless of
SOC-On or SOC-Off settings. Similar findings were observed
for MFR and ΔMBF, with reduced MFR variability using
SOC-On versus SOC-Off (𝑝 < 0.0001) and reduced ΔMBF
variability using SOC-On versus SOC-Off (𝑝 < 0.0001)
with an additional significant difference for Blood-ROI versus
Uptake-ROI (𝑝 < 0.05).
3.5. Nonconvergence of the DelayMethod. In the delaymodel,
the transport delay parameter failed to converge in 57%
of all sectors (𝑛 = 496 × 13 × 4), resulting in lower or
upper boundary limits (0 or 10 s, resp.). Sample FlowQuant
reports with Delay-Off and Delay-On are demonstrated in
the Supplemental Material, SM 1 and SM 2, available online
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Figure 3: Myocardial blood flow values (for all 3 coronary territories combined), using each method. The method with the best test-retest
repeatability was selected as the reference method to which other methods were subsequently compared (grey highlight). Delay-On (dark
grey) is presented only as a variant of the reference method, for comparison.
Table 2: Patient hemodynamics (𝑛 = 12).
Parameter Rest 1 Rest 2 Stress 1 Stress 2
HR (bpm)∗ 65 ± 8 65 ± 8 84 ± 13 83 ± 11
Systolic BP (mmHg) 124 ± 11 123 ± 10 129 ± 19 123 ± 16
Diastolic BP (mmHg) 73 ± 8 73 ± 6 76 ± 13 70 ± 11
HR × sys. BP (bpm ×mmHg)∗ 8092 ± 1242 8083 ± 1301 10869 ± 2549 10197 ± 2169
∗𝑝 < 0.05 for all rest versus stress.
𝑝 = ns for Rest 1 versus Rest 2 and Stress 1 versus Stress 2 for all parameters.
Table 3: Uptake (𝐾1), flow (MBF), TBV (total blood volume), and 𝛽 (fraction of pure blood signal) values for reference method.
Parameter Rest 1 Rest 2 Stress 1 Stress 2
𝐾∗1 [mL/min/g] 0.51 ± 0.08 0.50 ± 0.08 0.82 ± 0.12† 0.87 ± 0.15
MBF [mL/min/g]∗ 0.91 ± 0.25 0.88 ± 0.22 1.99 ± 0.45† 2.19 ± 0.45
MBF (RPP-adjusted)∗ [mL/min/g] 0.91 ± 0.23 0.89 ± 0.21 1.99 ± 0.51† 2.33 ± 0.62
TBV 0.28 ± 0.05 0.27 ± 0.05 0.31 ± 0.05† 0.30 ± 0.04
𝛽 0.81 ± 0.05 0.79 ± 0.03 0.86 ± 0.04† 0.85 ± 0.03
∗𝑝 < 0.05 for all rest versus stress.
†𝑝 < 0.05 between Rest 1 and Rest 2 and between Stress 1 and Stress 2.
at https://doi.org/10.1155/2017/6810626. In comparison, for all
the Delay-Off model variants, nonconvergence was observed
in only 0.3% of segments.
4. Discussion
In this work, we evaluated the test-retest repeatability of 82Rb
PET MBF, MFR, and ΔMBF values using several variants of
the 1-tissue-compartment kineticmodel analysis.While other
kinetic models do exist, we focused on this particular model
as it is the most widely accepted in the community [3] and
comparison between our referencemethod and the simplified
retention model was previously reported [6].
Our results suggest that the test-retest variability is the
lowest using the left atrium Blood-ROI, SOC-On, RBC-Off,
Delay-Off, and Global-DV.This conclusion is consistent with
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method (highlighted in grey). The single Delay-On variant is indicated with dark grey.
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Figure 5: Correlation (a) and relative Bland-Altman (b) analyses of test-retest flow (rest and stress in 3 coronary territories) values using the
reference method. Relative differences were expressed as a percentage of mean values, to account for increased variance at higher flow rates.
our previous work [5] using rest data alone in a separate
patient cohort and the same software analysis program.
The novelty of the current study is that it additionally
evaluates the use of RV blood spillover correction, arte-
rial blood transport delay, and a regional DV estimation.
Furthermore, this study adds stress MBF, MFR, and ΔMBF
repeatability measurements, which are pertinent to clinical
utility. The present work reinforces our earlier conclusions
that spillover correction, left atrium blood-pool derived
input function, and the use of a global DV constant are
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Figure 6: MBF: absolute test-retest flow differences (a, b, c, d) and relative flow differences (e, f, g, h) between model variants for rest and
stress flow values using SOC-On versus SOC-Off (a and e), RBC-On versus RBC-Off (b and f), Uptake-ROI versus Blood-ROI (c and g), and
Global-DV versus Regional-DV (d and h).
preferable for repeatable MBF measurements using 82Rb
PET.
In this work, we also determined that, with SOC-On
and Global-DV, 𝐾1 values were lower compared to those
of SOC-Off and Global-DV, consistent with a higher blood
peak of the spillover-corrected arterial blood TACs, as previ-
ously observed using factor analysis for spillover correction
[24]. SOC-Off MBF values were previously calibrated to
13N-ammonia-derived MBF values in a human population
[15] and have been shown to agree with other software
packages [3]. For this reason, SOC-Off Global-DV MBF
values were used as a reference to which SOC-On Global-
DV values were calibrated. Calibration to an external gold
standard (e.g., 13N-ammonia or 15O-water PET) was beyond
the scope of this work but may be warranted in future
studies.
4.1. Comparison to Previous Literature
4.1.1. Most Repeatable Method. To our knowledge, the lowest
test-retest variability for 82Rb PET MBF values has been
reported on a dataset that consisted of rest scans alone [5].
The rest-only repeatability coefficient in the present study
was 0.19mL/min/g or 21% relative to the mean, which is not
significantly different from those previously reported in a
separate cohort, 0.2mL/min/g, or 24% relative to the mean.
An outlier in stress flow values may be noted in Fig-
ure 5. Visual inspection revealed considerable motion on
the test-stress scan. Upon manual motion correction of the
reconstructed dynamic image sequence, the flow value was
reduced from 2.9mL/min/g to 2.4mL/min/g which is closer
to MBF value derived from the motion-free stress retest
data of 1.9mL/min/g. This suggests that patient motion can
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have a serious impact on MBF measurements and warrants
further work to detect and correct patient motion. Excluding
this patient from the cohort would maintain the stress-only
variability from 0.25mL/min/g or 14.0% to 0.25mL/min/g
or 14.8%, since RPCnp is robust to the presence of outliers.
However, none of the data used in this work was motion
corrected, as this was beyond the scope of this work and due
to missing ground truth to validate such correction.
Previous literature, without the use of SOC, has demon-
strated MBF variability with anatomical placement of the
arterial blood ROI (e.g., LV cavity, LA cavity, and aorta) [25].
While Vasquez et al. reported a bias, we noted that SOC-On
reduces the Blood-ROI (compared to Uptake-ROI) bias in
stress (0.16 to 0.12mL/min/g; 𝑝 < 0.00001) and delta (0.20
to 0.16mL/min/g; 𝑝 = 0.001), but not in rest or reserve (𝑝 >
0.05). It is worth noting that Klein et al. used the simplified
retention model, which does not account for the shape of the
blood input function and therefor may be more susceptible
to ROI variations [6].
We also found no significant difference in MBF values
between RVB samplings at the atrium or ventricle. However,
this data was not shown out of considerations for conciseness
and clarity—thus we opted to present the right atrium blood
sampled data in which myocardial tissue signal spillover
effects are smaller.
Another important contribution to the precision values
reported by our group is the use of constant-activity infusion
of the tracer over a 30-second interval as opposed to a fast
tracer bolus [6].
4.1.2. Study Design and Sources of Variability. In Klein et al.’s
study [11], we evaluated the operator-dependent variability in
MBF values for the same image analysis software. Intraoper-
ator variability (RPC) was in the range of 4 to 8%. Combined
rest and stress MBF RPC was <25% in this work, and thus
it may be argued (assuming noise adds in quadrature) that
only ∼5% of the measured test-retest variability is associated
with operator variability and the majority is associated
with physiologic changes in patient hemodynamics and
measurement noise. Although the experiment was designed
to achieve hemodynamic stability between test and retest,
some variation is to be expected. Regardless, these results
highlight the degree of uncertainty inMBF, MFR, and ΔMBF
measurements that can be expected in a human population
using 82Rb PET and current image analysis methods.
4.2. Nonconvergence of the Delay Method. The addition of
a blood transport delay parameter to the model resulted
in poor convergence. Work in other modalities, including
microbubble contrast enhanced (MCE) echocardiography
and contrast enhanced dynamic X-ray computed tomogra-
phy, has clearly demonstrated that the transport delay is on
the order of 1-2 cardiac cycles (i.e., 1-2 sec) [26]. In the current
work, temporal resolution was limited to 10 sec time frames,
which likely resulted in insufficient temporal resolution to
adequately resolve the transit time.
Reconstruction of shorter time frames has previously
been investigated [27], but at the cost of higher image noise
due to lower count statistics. We were not able to evaluate the
effect of shorter time frames on the delay enabled model as
the list-mode data was not available post hoc. It is unclear
whether the delayed model may be beneficial with faster
temporal sampling in 82Rb PET.
4.3. ROI Size. Blood-ROI and Uptake-ROI sizes were 4.8 ±
0.6mL versus 28.5 ± 7.8mL, respectively. Thus, Blood-ROIs
were smaller and more reproducible in size than Uptake-
ROIs. Since the blood input function is an average of voxels
within the ROI, the ROI size is secondary to the position of
the ROI relative to anatomical structures. Nevertheless, ROI
selection did not significantly impact MBF repeatability in
this work.
4.4. Applications. This study quantifies the test-retest vari-
ability associated with the entire imaging pipeline from
acquisition to kinetic modeling and is therefore impor-
tant for quantifying the repeatability of MBF, MFR, and
ΔMBF quantification using 82Rb PET imaging. In clinical
applications, these estimates are important for establishing
confidence intervals when comparing individual scans to
normal reference database values and for evaluation of serial
changes in response to disease progression and/or therapy. In
a research setting, these estimates are essential for planning
sample sizes to detect significant experimental effects.
4.5. Study Limitations. The primary limitation of this work is
the relatively small number of patients (𝑛 = 12). Nevertheless,
we were able to demonstrate statistically significant RPC
differences between several model variants.
While the results of this work demonstrate the superiority
of the reference method for test-retest repeatability, the
absolute and relative RPC values disclosed in the work are
only applicable to our specific patient population, constant-
activity rubidium infusion, PET scanner, image recon-
struction protocol, image analysis methods, and software.
Repeatability measurements may differ depending on these
and perhaps other factors, such as image binning protocols,
image segmentation and sampling, time-frame weighting,
and extraction correction. However, these factors are not the
focus of the work presented herein.
The stress test and retest measurements were not per-
formed under identical hemodynamic conditions due to
administration of dipyridamole and aminophylline relative
to times of acquisition. However, there were no significant
differences in hemodynamic parameters (heart rate or blood
pressure) or in stress MBF values between test and retest.
Furthermore, any differences in the experimental conditions
would likely result in increased variability between measure-
ments, and as such the reported repeatability measures serve
as an upper limit of the true single-stress test-retest variability.
Finally, while this work did not directly evaluate the
accuracy of MBF measurements against a gold standard, we
adjusted for knownMBF biases in the SOC-Onmethod using
a surrogate method (i.e., SOC-Off), which was previously
calibrated for accuracy using 13N-ammonia PET in healthy
normal subjects and CAD patients [22].
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5. Conclusions
Amongst several alternative 1-compartment model variants,
MBF, MFR, and ΔMBF repeatability was the best using
dual myocardium blood spillover correction and using a
global DV constant, while RV blood spillover correction
and arterial blood sampling ROI did not have a statistically
significant influence on repeatability. Temporal sampling was
insufficient to estimate blood transport delay.
The 95% limits of agreement for MBF values were less
than 25% of the mean at rest and stress, which may be
used clinically to determine confidence intervals for detecting
serial changes and comparison to population databases and
also to determine sample sizes in research studies, using 82Rb
PET MBF.
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